Shattuck Labs, Inc. (STTK) intrinsic value & 10-year financials

Shattuck Labs, Inc. (STTK) has a Graham intrinsic value of $33.20 per share. At $5.42 on Oct 17, 2026, the stock trades 84% below that value. Over the last 8 fiscal years revenue shrank 31.7% a year to $1.0M, with an average return on invested capital of -93.8%.

Graham intrinsic value
$33.20
Share price (Oct 17, 2026)
$5.42
Price vs Graham value
84% below
Market cap
$377.2M
Revenue (FY2025)
$1.0M
Revenue growth (8-yr CAGR)
-31.7%
ROIC (10-yr avg)
-93.8%
Free cash flow (FY2025)
-$40.0M

STTK 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.0M -$48.8M -$0.70 -$40.0M -5150.8% -188.9%
FY2024 $5.7M -$75.4M -$1.49 -$60.6M -1408.3% -341.2%
FY2023 $1.7M -$87.3M -$2.05 -$81.6M -5549.6% -118.3%
FY2022 $652.0K -$101.9M -$2.41 -$106.1M -15848.0% -66.1%
FY2021 $30.0M -$45.0M -$1.07 -$65.0M -150.8% -25.2%
FY2020 $9.9M -$36.6M -$2.36 -$34.4M -371.8% -26.8%
FY2019 $9.9M -$24.0M — -$21.4M -253.5% 109.9%
FY2018 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Shattuck Labs, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Shattuck Labs, Inc. has historically struggled to out-earn its cost of capital, averaging just -18.8% ROIC.

Shattuck Labs, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Shattuck Labs, Inc. is modeled at -31.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $33.20 per share.

STTK stock: frequently asked questions

What is the intrinsic value of Shattuck Labs, Inc. (STTK) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -31.7% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, STTK's intrinsic value is about $33.20 per share.

Is STTK stock undervalued?

At $5.42 (close on Oct 17, 2026), STTK trades 84% below its Graham value of $33.20. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

Does Shattuck Labs, Inc. generate free cash flow?

Shattuck Labs, Inc. generated -$40.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 7 reported years.

What is STTK's return on invested capital?

Average ROIC over the last 8 fiscal years was -93.8%, and average return on equity was -23.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this STTK data come from?

From Shattuck Labs, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 7, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks